Roche (ROG) vs Novartis (NOVN)
Roche (ROG) and Novartis (NOVN) side by side: both in Healthcare, both listed on SIX Swiss Exchange. Roche is the larger of the two by approximate market capitalization (about 1.1×).
| Field | Roche | Novartis |
|---|---|---|
| Legal name | Roche Holding AG | Novartis AG |
| Ticker | ROG | NOVN |
| Exchange | SIX Swiss Exchange XSWX | SIX Swiss Exchange XSWX |
| Jurisdiction | Switzerland | Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals and diagnostics | Pharmaceuticals |
| Market cap ≈ | $260bn | $230bn |
| Founded | 1896 | 1996 |
| Reporting currency | CHF | CHF |
| LEI | 549300U41AUUVOAAOB37 | 5493007HIVTX6SY6XD66 |
| ISIN | CH0012032048 | CH0012005267 |
| FIGI | BBG001SD12S2 | BBG001SD31N7 |
| Index membership | — | — |
| Held by (covered funds) | — | — |
Roche
Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.
Novartis
Basel-based pharmaceutical company created by the 1996 merger of Ciba-Geigy and Sandoz, now a pure-play innovative-medicines business after spinning off Alcon and Sandoz. Key franchises include cardiovascular, oncology and immunology drugs.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/roche · /api/v1/companies/novartis